Posted on 10/14/20
Novavax Will Seek a Combo Vaccine for Flu and COVID-19
While Novavax (NASDAQ:NVAX) is racing to bring its coronavirus vaccine candidate to market as fast as possible, the company is also planning for a post-pandemic future. . . .
Posted on 10/13/20
Howard County General Hospital Offers Resources for New Parents
Howard County General Hospital is offering online and virtual courses about childbirth, breastfeeding and newborns as well as online support group meetings and virtual birthing center . . .
Posted on 10/13/20
Sickle Cell Disease Association of America and Aruvant Sciences Forge New Partnership
The Sickle Cell Disease Association of America (SCDAA) and Aruvant Sciences are proud to announce a new partnership to create educational programs to increase awareness of . . .
Posted on 10/13/20
RegeneRx Expects to Complete Short-Term Financing
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration announced that it has verbally agreed to a short-term . . .
Posted on 10/12/20
Planet Fitness Celebrating Columbia Grand Opening, Oct. 16-22
TIMONIUM, Md. (Oct. 12, 2020) –Planet Fitness – one of the nation’s largest and fastest-growing franchisors and operators of fitness centers with more members than any . . .
Posted on 10/12/20
Outdoor Flu Shot Clinics at Farragut Square
Golden Triangle BID and CVS Health Partner to Offer Flu Shot Clinics in October The Golden Triangle Business Improvement District (BID) has partnered with CVS Health . . .
Posted on 10/9/20
Urosurgical Center of Richmond is the First Ambulatory Surgery Center in Virginia
RICHMOND, Va.--(BUSINESS WIRE)--As healthcare facilities look for new and innovative ways to battle multi-drug resistant organisms that can pose a risk to patient safety, Urosurgical Center . . .
Posted on 10/8/20
Howard County General Hospital’s State of Health Care Addresses COVID-19
Howard County General Hospital will host the third annual State of Health Care in Howard County, presenting “The COVID-19 Effect: Your Health and Care” virtually on . . .
Posted on 10/8/20
DARPA Awards Moderna up to $56 Million
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, . . .
Posted on 10/8/20
Sensei Biotherapeutics Announces $28.5 Million Financing
Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing personalized yet off the shelf immunotherapies for cancer and infectious diseases
Posted on 10/8/20
Q&A with David Krajewski, EVP and CFO of LifeBridge Health
For this week’s interview, ?David Nevins, President and CEO of Nevins and Associates, spoke with David Krajewski
Posted on 10/7/20
Enterprise Therapeutics Acquired By Rochee
Epidarex Capital, a transatlantic life science venture firm, announces that the lead program of its portfolio company Enterprise Therapeutics Ltd has been fully acquired by Roche
Posted on 10/7/20
Why Is Everyone Talking About Novavax Stock?
Any stock that skyrockets over 4,600% from the beginning of a year through early August is bound to create a lot of buzz in the investment . . .
Posted on 10/6/20
Averhealth Acquires American Court Services
Averhealth, a provider of substance use monitoring and treatment services tailored to the unique needs of courts and social service agencies, along with the support of . . .
Posted on 10/6/20
Curation Health Raises Series A Financing
Curation Health — creators of an advanced clinical decision support platform for value-based care — has announced completion of a Series A financing for an undisclosed . . .
Posted on 10/5/20
Sickle Cell Disease Association Holds 48th Annual National Convention Virtually
Sickle Cell Disease Association of America will hold its 48th annual national convention virtually this year from Tuesday, Oct. 13, through Saturday, Oct. 17. The four-day . . .
Posted on 10/5/20
Will Big Pharma Acquire Novavax?
Novavax (NASDAQ:NVAX) has had a phenomenal year in 2020. The mid-cap opened in January as a micro-cap, starting off the year at $4 a share. Nine . . .
Posted on 10/2/20
Owens & Minor Prices Offering of Common Stock
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced that it has priced its underwritten public offering of 8,475,000 shares of its common stock at . . .
Posted on 10/2/20
Gaithersburg’s Novavax Moves into Phase 3 of its of COVID-19 Vaccine Trial
After beginning clinical trials in May, Gaithersburg, Maryland-based Novavax has moved its COVID-19
Posted on 10/1/20
Oxford Finance Closes Credit Facility to Valor Healthcare
Oxford Finance LLC, a specialty finance firm that provides senior debt to healthcare services and life sciences companies worldwide, today announced the closing of a senior . . .
Posted on 9/30/20
Lorien Health Services First in State to Certify in Parkinson’s Disease Care
Will Hold Online Speaker Series for Parkinson’s Disease Community Lorien Health Services, a family-owned assisted living, nursing home, and residential services company, announced its Encore assisted . . .
Posted on 9/30/20
Interview with Ted Quinn, CEO & Founder of Activate Care
Ted Quinn is the CEO and Co-founder of Activate Care, a digital health company helping everybody engaged in
Posted on 9/30/20
Owens & Minor Announces Offering of Common Stock
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock. . . .
Posted on 9/29/20
CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced a restructuring of its partnership . . .
Posted on 9/24/20
Novavax Initiates Pivotal Study of COVID-19 Vaccine Candidate; Shares Up 5%
Novavax (NASDAQ:NVAX) launches a U.K.-based Phase 3 clinical trial evaluating COVID-19 vaccine candidate NVX-CoV2373 in up to 10K adult (ages 18-84) volunteers.Enrollment in the study, being . . .
Washington DC
